Douglas Jermasek - 28 Jul 2025 Form 4 Insider Report for Unicycive Therapeutics, Inc. (UNCY)

Role
EVP of Corporate Strategy
Signature
/s/ Doug Jermasek
Issuer symbol
UNCY
Transactions as of
28 Jul 2025
Net transactions value
$0
Form type
4
Filing time
30 Jul 2025, 16:30:06 UTC
Previous filing
14 Aug 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Jermasek Douglas EVP of Corporate Strategy C/O UNICYCIVE THERAPEUTICS, LOS ALTOS /s/ Doug Jermasek 30 Jul 2025 0001955273

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UNCY Stock Options Award $0 +10,000 +4.9% $0.000000 215,500 28 Jul 2025 Common Stock 10,000 $4.71 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 2,500 of the stock options vest on first anniversary of the date of grant and 1/36th of the remaining options vest at the end of each successive month thereafter.